clinic file content for speech and voive therapy
speech and voice therapy clinical documentation assessment treatment
Head and Neck Cancer Survivorship Care
Page 21
speech language pathology clinic file voice disorders dysphonia management
Head and Neck Cancer Survivorship Care
Page 21
| Field | Details |
|---|---|
| Patient name | |
| Date of birth / Age | |
| Gender | |
| Contact information | |
| Referring physician | (ENT, neurologist, oncologist, GP) |
| Reason for referral | |
| Date of referral / intake | |
| Insurance / funding |
| Parameter | Normal Range |
|---|---|
| Fundamental frequency (F0) | M: 85–180 Hz / F: 165–255 Hz |
| Jitter (%) | < 1.04% |
| Shimmer (%) | < 3.81% |
| Noise-to-Harmonics Ratio (NHR) | < 0.19 |
| Maximum Phonation Time (MPT) | ≥ 15 seconds |
| Approach | Indication |
|---|---|
| Vocal hygiene counseling | All voice disorders |
| Resonant voice therapy (e.g., Lessac-Madsen) | Functional dysphonia, nodules |
| Lee Silverman Voice Treatment (LSVT LOUD) | Parkinson's disease / hypokinetic dysarthria |
| Manual circumlaryngeal therapy | Muscle tension dysphonia |
| Confidential voice / voice rest protocol | Acute laryngitis, post-surgical |
| Semi-occluded vocal tract exercises (SOVTE) | Nodules, polyps, functional dysphonia |
| Electrolarynx / tracheoesophageal voice training | Post-total laryngectomy |
| Prosthetic management (TEP) | Post-laryngectomy — managed by SLP |
| Behavioral articulation/resonance therapy | Palatal defects, glossectomy |
| Botulinum toxin support therapy | Spasmodic dysphonia (adjunct to ENT injection) |
According to Head and Neck Cancer Survivorship Care guidelines (p. 21): HNC survivors with communication disorders should be referred to a speech-language pathologist for assessment and management, with early assessment and intervention preferred (Level IA–IIA evidence).
speech and voice therapy services content for our clinic file
speech voice therapy services clinical protocols assessment tools
Head and Neck Cancer Survivorship Care
Page 21
voice disorders dysphonia dysarthria fluency resonance therapy interventions
Wilson’s Disease
Page 21
| Indication | Examples |
|---|---|
| Voice quality changes | Hoarseness, breathiness, roughness, strain |
| Pitch or loudness disturbances | Pitch breaks, reduced loudness, monotone |
| Vocal fatigue | Voice tires with use, worsens across the day |
| Aphonia | Complete loss of voice |
| Resonance disorders | Hypernasality, hyponasality |
| Dysarthria | Slurred, reduced intelligibility speech |
| Fluency disorders | Stuttering, cluttering |
| Post-surgical voice rehabilitation | Post-laryngectomy, post-thyroplasty |
| HNC-related communication disorders | Radiation-associated speech/voice changes |
⚠️ Urgent ENT referral first for: new or progressive hoarseness >3 weeks, stridor, hemoptysis, dysphagia with weight loss, or suspected malignancy — before SLP intake.
| Measure | Clinical Significance |
|---|---|
| Fundamental frequency (F0) | Pitch disorders, gender-affirming voice |
| Jitter & Shimmer | Vocal fold irregularity, organic pathology |
| Noise-to-Harmonics Ratio (NHR) | Breathiness, turbulent airflow |
| Maximum Phonation Time (MPT) | Breath support, glottic closure efficiency |
| Subglottal pressure / airflow | Phonatory effort, aerodynamic efficiency |
| Therapy Program | Target Condition |
|---|---|
| Vocal hygiene counseling & education | All voice disorders — first-line |
| Resonant voice therapy (Lessac-Madsen) | Functional dysphonia, vocal nodules |
| Semi-occluded vocal tract exercises (SOVTE) | Nodules, polyps, functional dysphonia, post-surgical |
| Manual circumlaryngeal therapy | Muscle tension dysphonia (MTD) |
| Confidential voice protocol | Acute laryngitis, vocal fold haemorrhage, early post-op |
| Accent Method | Functional and neurogenic dysphonia |
| Flow phonation techniques | Hyperfunction, MTD |
| Pitch and loudness shaping | Parkinson's, neurogenic disorders, gender-affirming voice |
| Dysarthria Type | Therapy Focus |
|---|---|
| Spastic | Relaxation techniques, reducing effort |
| Ataxic | Rate modification, prosody training |
| Hypokinetic (Parkinson's) | LSVT LOUD, loudness and articulation |
| Flaccid | Compensatory strategies, prosthetic options |
| Mixed | Combined approaches per dominant features |
| Specialty | Role in Voice/Speech Care |
|---|---|
| ENT / Laryngologist | Laryngoscopy, surgical intervention, botulinum toxin injection |
| Neurology | Neurogenic voice/speech disorders, tremor, Parkinson's |
| Oncology / Radiation Oncology | HNC-related communication disorders |
| Maxillofacial Prosthodontics | Palatal obturators, palatal drop prostheses |
| Gastroenterology | LPR/GERD management affecting voice |
| Psychology / Psychiatry | Psychogenic dysphonia, conversion aphonia, anxiety in stuttering |
| Dietitian | Post-laryngectomy, dysphagia overlap, nutritional support |
| Audiology | Hearing loss impact on voice and speech monitoring |
| Phase | Frequency | Duration |
|---|---|---|
| Initial assessment | Single extended session | 60–90 minutes |
| Active therapy (standard) | Weekly or twice weekly | 45–60 minutes |
| LSVT LOUD (intensive) | 4 sessions/week × 4 weeks | 60 minutes |
| Maintenance / review | Monthly or as needed | 30–45 minutes |
| Discharge review | Single session | 45–60 minutes |